All news

Haleon schedules Toronto Health House as Goldman keeps Buy for Haleon stock

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Haleon is scheduling a "Health House" event in Toronto for October 23, 2026, following a survey of Canadian consumers. This event will showcase brands like Advil and Sensodyne. Goldman Sachs has reiterated its Buy rating for Haleon stock, setting a price target of GBp 460.00, as the company prepares for its Q3 trading statement on October 29, 2026.

Read original source

HLN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.